The Thames Valley is proud to be the home of the second largest influenza vaccine provider in the world, with their headquarters and global research and development program located in Maidenhead.
Seqirus are one of a significant cluster of companies in the Life Sciences and Healthcare sector based in the Thames Valley.
In 2021, the UK and Australia signed a Free Trade Agreement (FTA), building on existing strengths in two-way trade and investment, supporting post-COVID economic recovery and signaling shared commitment to global trade.
An important part of what the UK-Australia FTA is delivering is investment – the UK was the second-largest destination for Australian foreign investment, with FDI of A$135 billion in 2021.
This FTA offers a golden opportunity to further cement the relationship between the UK and Australia.
According to the Department for International Trade’s – Trade and Investment statistic, total trade in goods and services between the UK and New Zealand was £2.4 billion in the four quarters to the end of Q2 2022.
In 2020 (the latest year for which data is available) the inward stock of foreign direct investment (FDI) in the UK from New Zealand was £806 million.
Most notably, in 2022, the UK and New Zealand signed a Free Trade Agreement (FTA) – however, both countries are first required to complete their respective domestic procedures for the agreement to come into effect.